Report Detail

Request for Sample of this report

Other Global Medical Second Opinion Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4714039
    • |
  • 29 June, 2026
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Medical Second Opinion market size was valued at US$ 8068 million in 2025 and is forecast to a readjusted size of US$ 20550 million by 2032 with a CAGR of 14.5% during review period.
Medical Second Opinion refers to a professional healthcare service where a patient, after receiving an initial diagnosis or treatment recommendation, consults an independent, qualified medical expert for a reevaluation. This may include a review of diagnosis, therapeutic plan, or surgical necessity. The service is typically delivered through remote consultations, online platforms, or international collaborations, especially in cases involving critical illness, rare diseases, or complex interventions. It aims to reduce misdiagnosis, enhance treatment accuracy, and build patient confidence. With the advancement of telemedicine, global healthcare connectivity, and AI-driven diagnostics, Medical Second Opinion is emerging as a critical component in premium healthcare offerings, insurance services, and cross-border referral ecosystems.
As medical decisions become more complex, the market for Medical Second Opinion services is experiencing rapid growth. According to annual reports, global high-net-worth and middle-class populations are increasingly seeking access to premium healthcare resources, especially in oncology, cardiovascular diseases, and rare conditions where patients demand confirmation and optimized treatment plans. Insurance providers are embedding second opinion services into critical illness and health insurance products, improving customer engagement and loyalty. Governments in countries like the U.S., Germany, and Singapore have incorporated second opinions into reimbursement or legal frameworks, enhancing credibility. Meanwhile, the integration of AI-assisted diagnostics, international telemedicine platforms, and global medical expert networks has significantly improved the accessibility and accuracy of these services.
Despite growing interest, Medical Second Opinion services face systemic and operational barriers. Cross-border service delivery is complicated by diverse healthcare systems, lack of standardized medical records, and data interoperability issues. High-level medical expertise remains concentrated in a few top institutions, limiting supply-side scalability. In many regions, payment mechanisms are unclear, and insurance coverage is insufficient to support widespread adoption. Additionally, concerns about data privacy and regulatory compliance for cross-border data sharing pose legal risks. For emerging providers, building trust networks of qualified physicians, ensuring consistent service quality, and forming hospital partnerships are critical but challenging.
Driven by the rise of personalized medicine and patient empowerment, Medical Second Opinion services are evolving from a niche premium add-on to a standard component of clinical care. Integrated packages offering “diagnosis + expert review” are gaining popularity, particularly for cancers, cardiovascular, and neurological diseases. Digital health platforms and telemedicine providers are embedding second opinion modules into broader ecosystems that include AI imaging analysis, auto-structured medical records, and access to international experts. In fast-growing regions such as Asia and the Middle East, high-net-worth individuals and critical illness policyholders are fueling adoption, pushing the industry toward greater personalization, globalization, and platform-based models.
This report is a detailed and comprehensive analysis for global Medical Second Opinion market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Second Opinion market size and forecasts, in consumption value ($ Million), 2021-2032
Global Medical Second Opinion market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Medical Second Opinion market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Medical Second Opinion market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Second Opinion
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Second Opinion market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include HCA Hospitals, AXA PPP Healthcare, Royal London Group, Helsana Group, Cleveland Clinic, Amradnet, Best Doctors, Inova Care, Toranomon Hospital, Keio University Hospital, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Medical Second Opinion market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hospitals
Medical Second Opinion Providing Companies
Health Insurance Companies
Market segment by Application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
Market segment by players, this report covers
HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Medical Second Opinion product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Medical Second Opinion, with revenue, gross margin, and global market share of Medical Second Opinion from 2021 to 2026.
Chapter 3, the Medical Second Opinion competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Medical Second Opinion market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Second Opinion.
Chapter 13, to describe Medical Second Opinion research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Medical Second Opinion by Type
    • 1.3.1 Overview: Global Medical Second Opinion Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Medical Second Opinion Consumption Value Market Share by Type in 2025
    • 1.3.3 Hospitals
    • 1.3.4 Medical Second Opinion Providing Companies
    • 1.3.5 Health Insurance Companies
  • 1.4 Global Medical Second Opinion Market by Application
    • 1.4.1 Overview: Global Medical Second Opinion Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cancer
    • 1.4.3 Diabetes
    • 1.4.4 Cardiac Disorders
    • 1.4.5 Neurological Disorders
    • 1.4.6 Ocular Disorders
    • 1.4.7 Others
  • 1.5 Global Medical Second Opinion Market Size & Forecast
  • 1.6 Global Medical Second Opinion Market Size and Forecast by Region
    • 1.6.1 Global Medical Second Opinion Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Medical Second Opinion Market Size by Region, (2021-2032)
    • 1.6.3 North America Medical Second Opinion Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Medical Second Opinion Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Medical Second Opinion Market Size and Prospect (2021-2032)
    • 1.6.6 South America Medical Second Opinion Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Medical Second Opinion Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 HCA Hospitals
    • 2.1.1 HCA Hospitals Details
    • 2.1.2 HCA Hospitals Major Business
    • 2.1.3 HCA Hospitals Medical Second Opinion Product and Solutions
    • 2.1.4 HCA Hospitals Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 HCA Hospitals Recent Developments and Future Plans
  • 2.2 AXA PPP Healthcare
    • 2.2.1 AXA PPP Healthcare Details
    • 2.2.2 AXA PPP Healthcare Major Business
    • 2.2.3 AXA PPP Healthcare Medical Second Opinion Product and Solutions
    • 2.2.4 AXA PPP Healthcare Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AXA PPP Healthcare Recent Developments and Future Plans
  • 2.3 Royal London Group
    • 2.3.1 Royal London Group Details
    • 2.3.2 Royal London Group Major Business
    • 2.3.3 Royal London Group Medical Second Opinion Product and Solutions
    • 2.3.4 Royal London Group Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Royal London Group Recent Developments and Future Plans
  • 2.4 Helsana Group
    • 2.4.1 Helsana Group Details
    • 2.4.2 Helsana Group Major Business
    • 2.4.3 Helsana Group Medical Second Opinion Product and Solutions
    • 2.4.4 Helsana Group Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Helsana Group Recent Developments and Future Plans
  • 2.5 Cleveland Clinic
    • 2.5.1 Cleveland Clinic Details
    • 2.5.2 Cleveland Clinic Major Business
    • 2.5.3 Cleveland Clinic Medical Second Opinion Product and Solutions
    • 2.5.4 Cleveland Clinic Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cleveland Clinic Recent Developments and Future Plans
  • 2.6 Amradnet
    • 2.6.1 Amradnet Details
    • 2.6.2 Amradnet Major Business
    • 2.6.3 Amradnet Medical Second Opinion Product and Solutions
    • 2.6.4 Amradnet Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Amradnet Recent Developments and Future Plans
  • 2.7 Best Doctors
    • 2.7.1 Best Doctors Details
    • 2.7.2 Best Doctors Major Business
    • 2.7.3 Best Doctors Medical Second Opinion Product and Solutions
    • 2.7.4 Best Doctors Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Best Doctors Recent Developments and Future Plans
  • 2.8 Inova Care
    • 2.8.1 Inova Care Details
    • 2.8.2 Inova Care Major Business
    • 2.8.3 Inova Care Medical Second Opinion Product and Solutions
    • 2.8.4 Inova Care Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Inova Care Recent Developments and Future Plans
  • 2.9 Toranomon Hospital
    • 2.9.1 Toranomon Hospital Details
    • 2.9.2 Toranomon Hospital Major Business
    • 2.9.3 Toranomon Hospital Medical Second Opinion Product and Solutions
    • 2.9.4 Toranomon Hospital Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Toranomon Hospital Recent Developments and Future Plans
  • 2.10 Keio University Hospital
    • 2.10.1 Keio University Hospital Details
    • 2.10.2 Keio University Hospital Major Business
    • 2.10.3 Keio University Hospital Medical Second Opinion Product and Solutions
    • 2.10.4 Keio University Hospital Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Keio University Hospital Recent Developments and Future Plans
  • 2.11 Johns Hopkins Medicine
    • 2.11.1 Johns Hopkins Medicine Details
    • 2.11.2 Johns Hopkins Medicine Major Business
    • 2.11.3 Johns Hopkins Medicine Medical Second Opinion Product and Solutions
    • 2.11.4 Johns Hopkins Medicine Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Johns Hopkins Medicine Recent Developments and Future Plans
  • 2.12 Penn Medicine
    • 2.12.1 Penn Medicine Details
    • 2.12.2 Penn Medicine Major Business
    • 2.12.3 Penn Medicine Medical Second Opinion Product and Solutions
    • 2.12.4 Penn Medicine Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Penn Medicine Recent Developments and Future Plans
  • 2.13 Oncology International Pvt. Ltd.
    • 2.13.1 Oncology International Pvt. Ltd. Details
    • 2.13.2 Oncology International Pvt. Ltd. Major Business
    • 2.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Product and Solutions
    • 2.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Oncology International Pvt. Ltd. Recent Developments and Future Plans
  • 2.14 GrandOpinion
    • 2.14.1 GrandOpinion Details
    • 2.14.2 GrandOpinion Major Business
    • 2.14.3 GrandOpinion Medical Second Opinion Product and Solutions
    • 2.14.4 GrandOpinion Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 GrandOpinion Recent Developments and Future Plans
  • 2.15 London Pain Clinic
    • 2.15.1 London Pain Clinic Details
    • 2.15.2 London Pain Clinic Major Business
    • 2.15.3 London Pain Clinic Medical Second Opinion Product and Solutions
    • 2.15.4 London Pain Clinic Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 London Pain Clinic Recent Developments and Future Plans
  • 2.16 Mondial Assistance
    • 2.16.1 Mondial Assistance Details
    • 2.16.2 Mondial Assistance Major Business
    • 2.16.3 Mondial Assistance Medical Second Opinion Product and Solutions
    • 2.16.4 Mondial Assistance Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Mondial Assistance Recent Developments and Future Plans
  • 2.17 Medisense
    • 2.17.1 Medisense Details
    • 2.17.2 Medisense Major Business
    • 2.17.3 Medisense Medical Second Opinion Product and Solutions
    • 2.17.4 Medisense Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Medisense Recent Developments and Future Plans
  • 2.18 Medo Asia Sdn. Bhd.
    • 2.18.1 Medo Asia Sdn. Bhd. Details
    • 2.18.2 Medo Asia Sdn. Bhd. Major Business
    • 2.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Product and Solutions
    • 2.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Medo Asia Sdn. Bhd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Medical Second Opinion Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Medical Second Opinion by Company Revenue
    • 3.2.2 Top 3 Medical Second Opinion Players Market Share in 2025
    • 3.2.3 Top 6 Medical Second Opinion Players Market Share in 2025
  • 3.3 Medical Second Opinion Market: Overall Company Footprint Analysis
    • 3.3.1 Medical Second Opinion Market: Region Footprint
    • 3.3.2 Medical Second Opinion Market: Company Product Type Footprint
    • 3.3.3 Medical Second Opinion Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Medical Second Opinion Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Medical Second Opinion Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Medical Second Opinion Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Medical Second Opinion Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Medical Second Opinion Consumption Value by Type (2021-2032)
  • 6.2 North America Medical Second Opinion Market Size by Application (2021-2032)
  • 6.3 North America Medical Second Opinion Market Size by Country
    • 6.3.1 North America Medical Second Opinion Consumption Value by Country (2021-2032)
    • 6.3.2 United States Medical Second Opinion Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Medical Second Opinion Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Medical Second Opinion Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Medical Second Opinion Consumption Value by Type (2021-2032)
  • 7.2 Europe Medical Second Opinion Consumption Value by Application (2021-2032)
  • 7.3 Europe Medical Second Opinion Market Size by Country
    • 7.3.1 Europe Medical Second Opinion Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Medical Second Opinion Market Size and Forecast (2021-2032)
    • 7.3.3 France Medical Second Opinion Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Medical Second Opinion Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Medical Second Opinion Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Medical Second Opinion Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Medical Second Opinion Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Medical Second Opinion Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Medical Second Opinion Market Size by Region
    • 8.3.1 Asia-Pacific Medical Second Opinion Consumption Value by Region (2021-2032)
    • 8.3.2 China Medical Second Opinion Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Medical Second Opinion Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Medical Second Opinion Market Size and Forecast (2021-2032)
    • 8.3.5 India Medical Second Opinion Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Medical Second Opinion Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Medical Second Opinion Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Medical Second Opinion Consumption Value by Type (2021-2032)
  • 9.2 South America Medical Second Opinion Consumption Value by Application (2021-2032)
  • 9.3 South America Medical Second Opinion Market Size by Country
    • 9.3.1 South America Medical Second Opinion Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Medical Second Opinion Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Medical Second Opinion Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Medical Second Opinion Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Medical Second Opinion Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Medical Second Opinion Market Size by Country
    • 10.3.1 Middle East & Africa Medical Second Opinion Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Medical Second Opinion Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Medical Second Opinion Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Medical Second Opinion Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Medical Second Opinion Market Drivers
  • 11.2 Medical Second Opinion Market Restraints
  • 11.3 Medical Second Opinion Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Medical Second Opinion Industry Chain
  • 12.2 Medical Second Opinion Upstream Analysis
  • 12.3 Medical Second Opinion Midstream Analysis
  • 12.4 Medical Second Opinion Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Second Opinion. Industry analysis & Market Report on Medical Second Opinion is a syndicated market report, published as Global Medical Second Opinion Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Second Opinion market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo